Florida Retina Institute - Jacksonville Southside — Jacksonville, Florida

Florida Retina Institute - Jacksonville Southside is a clinical research site located in Jacksonville, Florida, United States 32216.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Florida Retina Institute - Jacksonville Southside has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy.

Sponsors: Vantage Biosciences Ltd.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Jacksonville

Browse all research sites in Florida · View every site in Jacksonville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Florida Retina Institute - Jacksonville Southside?

Florida Retina Institute - Jacksonville Southside has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Florida Retina Institute - Jacksonville Southside conducted?

Florida Retina Institute - Jacksonville Southside has 1 clinical trials on record, with 1 currently active. Their work covers Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy.

Is Florida Retina Institute - Jacksonville Southside accredited by Crixeo Clinical Trials?

Florida Retina Institute - Jacksonville Southside has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Florida Retina Institute - Jacksonville Southside?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.